Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the ...
8dOpinion
The Trump administration is impeding the National Institutes of Health-backed science that enabled treatment of ...
At the Tandem Meetings 2025, researchers presented a study of scalp cooling in patients undergoing chemotherapy and ASCT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback